GNT Pharma Announces Approval of IND Application for the Phase III RODIN Trial of Nelonemdaz for Acute Ischemic Stroke Patients PIII Study for 496 ischemic stroke patients treated with endovascular thrombectomyFirst multi-target neuroprotectant for the intervention of ischemic brain injurySafety and efficacy verified in two...

RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15...

Participants needed for brain injury research studies at Kessler Foundation EAST HANOVER, N.J., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation is recruiting study participants for multiple research programs aimed at improving cognition, mobility, and long-term outcomes...

Mesoblast's Mesenchymal Precursor Cells Induce Functional Recovery in Ischemic Stroke Model NEW YORK and MELBOURNE, Australia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced positive preclinical trial results which...